【正文】 ge annual growth rateSource: SRI Consulting “Active Pharmaceutical Ingredients” 20232023/3/1 星期一34求實創(chuàng)新勤奮嚴謹Pharmaceutical Global API Manufacturing Establishments 2023Source: Newport Horizon Sourcing, October 20232023/3/1 星期一35求實創(chuàng)新勤奮嚴謹Pharmaceutical Source: SRI Consulting “Active Pharmaceutical Ingredients” 2023Currently, India and China account for about 40 49% of the production of the global API （ Active Pharmaceutical Ingredients） supply, but within the next 10 – 15 years most experts predict that China and India will account for 80% of the global API production2023/3/1 星期一36求實創(chuàng)新勤奮嚴謹Pharmaceutical Future Trends Impacting API Production and Sales? Over the next 5 years a significant number of blockbuster drugs will lose patent protection? Pharmaceutical manufactures will expand outsourcing of APIs for difficult or hazardous chemical synthesis steps, bulk intermediates and active ingredients ? China and India are currently able to meet industry’s needs for lowvalue APIs? Over the next 5 – 10 years India and China will also meet industry’s needs for highvalue and more plex APIs2023/3/1 星期一37求實創(chuàng)新勤奮嚴謹Pharmaceutical China – Structure of the Industry? There are over 4,000 API and pharmaceutical manufacturers? The biotechnology industry is one of the fastestgrowing segments? Technologies are not as advanced as in the . and Europe? Only 5% of China’s API and doseform manufacturers meet GMP standards? India and China API production is essentially not regulated and is adding to global problems of counterfeit and substandard medicinesSource: SRI Consulting “Active Pharmaceutical Ingredients” 20232023/3/1 星期一38求實創(chuàng)新勤奮嚴謹Pharmaceutical 二、藥品檢驗工作的基本程序省市、地州、縣的藥品檢驗所。檢查（ Test）雜質(zhì) /純度（ 進一步閱讀資料：中國藥典 2023年版一部、二部、三部本章要求2023/3/1 星期一46求實創(chuàng)新勤奮嚴謹Pharmaceutical 謝謝觀看 /歡迎下載BY FAITH I MEAN A VISION OF GOOD ONE CHERISHES AND THE ENTHUSIASM THAT PUSHES ONE TO SEEK ITS FULFILLMENT REGARDLESS OF OBSTACLES. BY FAITH I BY FAITH